Press

The FDA needs to set standards for using artificial intelligence in drug development

Charles Fisher

Opinion: Poorly constructed AI algorithms for drug discovery and testing have the potential to cause harm. The FDA should play an important role in ensuring that AI-based drug development tools meet appropriate standards.